Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-TNFSF13B, LymphoStat-B Vector   (CAT#: GTVCR-WQ1789MR)

This product GTVCR-WQ1789MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting TNFSF13B. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Homo sapiens
RefSeq NM_001145645.2
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 10673
UniProt ID Q9Y275
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-TNFSF13B, LymphoStat-B Vector (GTVCR-WQ1789MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1295MR IVTScrip™ pT7-VEE-mRNA-Anti-GLP1R, GLP-1Fc Vector Vector GLP-1Fc
GTVCR-WQ840MR IVTScrip™ pT7-VEE-mRNA-Anti-ITGA2B&ITGB3, C4G1 Vector Vector C4G1
GTVCR-WQ393MR IVTScrip™ pSP6-VEE-mRNA-Anti-C5, ALXN-1210 Vector Vector ALXN-1210
GTVCR-WQ740MR IVTScrip™ pT7-VEE-mRNA-Anti-B7, BMS-224818 Vector Vector BMS-224818
GTVCR-WQ89MR IVTScrip™ pSP6-VEE-mRNA-Anti-SELP, 42-89-glycoprotein Vector Vector 42-89-glycoprotein
GTVCR-WQ2448MR IVTScrip™ pT7-VEE-mRNA-Anti-DLL3, SC0001-SCX Vector Vector SC0001-SCX
GTVCR-WQ2611MR IVTScrip™ pT7-VEE-mRNA-Anti-TNFRSF13C, VAY-736 Vector Vector VAY-736
GTVCR-WQ977MR IVTScrip™ pSP6-VEE-mRNA-Anti-CD40, CFZ-533 Vector Vector CFZ-533
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.